Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids

Kieler-Ferguson, Heidi M.; Chan, Darren; Sockolosky, Jonathan; Finney, Lydia; Maxey, Evan; Vogt, Stefan; Szoka, Jr., Francis C.

doi:10.1016/j.ejps.2017.03.003

Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids

Journal Article · Fri Mar 03 04:00:00 EST 2017 · European Journal of Pharmaceutical Sciences

DOI:https://doi.org/10.1016/j.ejps.2017.03.003· OSTI ID:1377594

Kieler-Ferguson, Heidi M. ^[1]; ^[2]; Sockolosky, Jonathan ^[3]; Finney, Lydia ^[4]; Maxey, Evan ^[4]; Vogt, Stefan ^[4]; Szoka, Jr., Francis C. ^[5]

Univ. of California, Berkeley, CA (United States); Univ. of California, San Francisco, CA (United States); Merck Research Labs., Boston, MA (United States); Merck & Co., Inc., Kenilworth, NJ (United States)
Univ. of California, San Francisco, CA (United States); Univ. at Buffalo, Buffalo, NY (United States)
Univ. of California, San Francisco, CA (United States); Stanford Univ. School of Medicine, Stanford, CA (United States)
Argonne National Lab. (ANL), Argonne, IL (United States)
Univ. of California, San Francisco, CA (United States)

Here, we employed a recently introduced class of sterol-modified lipids (SML) to produce m-PEG-DSPE containing liposome compositions with a range of cis-platinum content release rates. SML have a cholesterol succinate attached to the phosphatidylglycerol head group and a fatty acid at the 2 position. These compositions were compared to the well-studied liposome phospholipid compositions: mPEG-DSPE/Hydrogenated Soy PC/cholesterol or mPEG-DSPE/POPC/cholesterol to determine the effect of the cis-platinum release extent on C26 tumor proliferation in the BALB/c colon carcinoma mouse model. The release rates of cis-platinum from liposomes composed of SML are a function of the acyl chain length. SML-liposomes with shorter acyl chain lengths C-8 provided more rapid cisplatin release, lower in vitro IC50, and were easier to formulate compared to liposomes using traditional phospholipid compositions. Similar to other liposome cis-platinum formulations, the half-life of m-PEG-DSPE SML liposome cisplatin is substantially longer than the free drug. This resulted in a higher tumor cisplatin concentration at 48 h post-dosing compared to the free drug and higher Pt-DNA adducts in the tumor. Moreover, the maximum tolerated dose of the liposome formulations where up to four fold greater than the free drug. Using X-ray fluorescence spectroscopy on tumor sections, we compared the location of platinum, to the location of a fluorescence lipid incorporated in the liposomes. The liposome platinum co-localized with the fluorescent lipid and both were non-uniformly distributed in the tumor. Non-encapsulated Cis-platinum, albeit at a low concentration, was more uniformly distributed thorough the tumor. Three liposome formulations, including the well studied hydrogenated HSPC composition, had better antitumor activity in the murine colon 26 carcinoma model as compared to the free drug at the same dose but the SML liposome platinum formulations did not perform better than the HSPC formulation.

View Accepted Manuscript (DOE)

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States)

Sponsoring Organization:: National Institutes of Health (NIH); USDOE

Grant/Contract Number:: AC02-06CH11357

OSTI ID:: 1377594

Journal Information:: European Journal of Pharmaceutical Sciences, Journal Name: European Journal of Pharmaceutical Sciences Journal Issue: C Vol. 103; ISSN 0928-0987

Publisher:: ElsevierCopyright Statement

Country of Publication:: United States

Language:: English

References (39)

Disterolphospholipids: Nonexchangeable Lipids and Their Application to Liposomal Drug Delivery Huang, Zhaohua; Jaafari, Mahmoud Reza; Szoka, Francis C. Angewandte Chemie, Vol. 121, Issue 23 https://doi.org/10.1002/ange.200900111	journal	May 2009
X-ray fluorescence microprobe imaging in biology and medicine Paunesku, Tatjana; Vogt, Stefan; Maser, Jörg Journal of Cellular Biochemistry, Vol. 99, Issue 6 https://doi.org/10.1002/jcb.21047	journal	January 2006
Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs: Clinical developments of chemotherapeutic nanomedicines Kieler-Ferguson, Heidi M.; Fréchet, Jean M. J.; Szoka Jr, Francis C. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 5, Issue 2 https://doi.org/10.1002/wnan.1209	journal	January 2013
One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes Yamada, Kanae; Kato, Naoyuki; Takagi, Akimitsu Analytical and Bioanalytical Chemistry, Vol. 382, Issue 7 https://doi.org/10.1007/s00216-005-3339-5	journal	June 2005
Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma Zamboni, William C.; Gervais, Anne C.; Egorin, Merrill J. Cancer Chemotherapy and Pharmacology, Vol. 53, Issue 4 https://doi.org/10.1007/s00280-003-0719-4	journal	April 2004
A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer Dragovich, Tomislav; Mendelson, David; Kurtin, Sandra Cancer Chemotherapy and Pharmacology, Vol. 58, Issue 6 https://doi.org/10.1007/s00280-006-0235-4	journal	May 2006
In vivo antitumor activity of cis-bis-neodecanoato-trans- R,R-l,2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes Mori, Atsuhide; Wu, Su-Ping; Han, Insook Cancer Chemotherapy and Pharmacology, Vol. 37, Issue 5 https://doi.org/10.1007/s002800050409	journal	March 1996
Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice Newman, Mary S.; Colbern, Gail T.; Working, Peter K. Cancer Chemotherapy and Pharmacology, Vol. 43, Issue 1 https://doi.org/10.1007/s002800050855	journal	January 1999
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin Meerum Terwogt, Jetske; Groenewegen, Gerard; Pluim, Dick Cancer Chemotherapy and Pharmacology, Vol. 49, Issue 3 https://doi.org/10.1007/s002800100371	journal	March 2002
The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells Hall, Matthew D.; Dillon, Carolyn T.; Zhang, Mei JBIC Journal of Biological Inorganic Chemistry, Vol. 8, Issue 7 https://doi.org/10.1007/s00775-003-0471-6	journal	July 2003
Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116 Tippayamontri, Thititip; Kotb, Rami; Paquette, Benoit Investigational New Drugs, Vol. 29, Issue 6 https://doi.org/10.1007/s10637-010-9494-3	journal	July 2010
Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance Peleg-Shulman, Tal; Gibson, Dan; Cohen, Rivka Biochimica et Biophysica Acta (BBA) - Biomembranes, Vol. 1510, Issue 1-2, p. 278-291 https://doi.org/10.1016/S0005-2736(00)00359-X	journal	February 2001
Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes Dos Santos, Nancy; Mayer, Lawrence D.; Abraham, Sheela A. Biochimica et Biophysica Acta (BBA) - Biomembranes, Vol. 1561, Issue 2 https://doi.org/10.1016/S0005-2736(02)00345-0	journal	April 2002
Nanocarriers for delivery of platinum anticancer drugs Oberoi, Hardeep S.; Nukolova, Natalia V.; Kabanov, Alexander V. Advanced Drug Delivery Reviews, Vol. 65, Issue 13-14 https://doi.org/10.1016/j.addr.2013.09.014	journal	November 2013
Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: In vitro and in vivo studies Marzban, Ehsan; Alavizadeh, Seyedeh Hoda; Ghiadi, Maral Colloids and Surfaces B: Biointerfaces, Vol. 136 https://doi.org/10.1016/j.colsurfb.2015.10.046	journal	December 2015
Preparation and evaluation of a novel liposomal formulation of cisplatin Zhou, Xiaoju; Wang, Jiong; Wu, Jianhong European Journal of Pharmaceutical Sciences, Vol. 66 https://doi.org/10.1016/j.ejps.2014.10.004	journal	January 2015
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposome Suzuki, Ryo; Takizawa, Tomoko; Kuwata, Yasuhiro International Journal of Pharmaceutics, Vol. 346, Issue 1-2 https://doi.org/10.1016/j.ijpharm.2007.06.010	journal	January 2008
Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes Woo, Janet; Chiu, Gigi N. C.; Karlsson, Göran International Journal of Pharmaceutics, Vol. 349, Issue 1-2 https://doi.org/10.1016/j.ijpharm.2007.07.020	journal	February 2008
Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells Hirai, M.; Minematsu, H.; Hiramatsu, Y. International Journal of Pharmaceutics, Vol. 391, Issue 1-2 https://doi.org/10.1016/j.ijpharm.2010.02.030	journal	May 2010
The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma Alavizadeh, Seyedeh Hoda; Badiee, Ali; Golmohammadzadeh, Shiva International Journal of Pharmaceutics, Vol. 473, Issue 1-2 https://doi.org/10.1016/j.ijpharm.2014.07.020	journal	October 2014
Ultrasound triggered release of cisplatin from liposomes in murine tumors Schroeder, Avi; Honen, Reuma; Turjeman, Keren Journal of Controlled Release, Vol. 137, Issue 1 https://doi.org/10.1016/j.jconrel.2009.03.007	journal	July 2009
A robust and quantitative method for tracking liposome contents after intravenous administration Kohli, Aditya G.; Kieler-Ferguson, Heidi M.; Chan, Darren Journal of Controlled Release, Vol. 176 https://doi.org/10.1016/j.jconrel.2013.12.014	journal	February 2014
Designer lipids for drug delivery: From heads to tails Kohli, Aditya G.; Kierstead, Paul H.; Venditto, Vincent J. Journal of Controlled Release, Vol. 190 https://doi.org/10.1016/j.jconrel.2014.04.047	journal	September 2014
The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours Hall, Matthew D.; Alderden, Rebecca A.; Zhang, Mei Journal of Structural Biology, Vol. 155, Issue 1 https://doi.org/10.1016/j.jsb.2006.01.011	journal	July 2006
Indocyanine Green-Loaded Liposomes for Light-Triggered Drug Release Lajunen, Tatu; Kontturi, Leena-Stiina; Viitala, Lauri Molecular Pharmaceutics, Vol. 13, Issue 6 https://doi.org/10.1021/acs.molpharmaceut.6b00207	journal	April 2016
Rates of spontaneous exchange of synthetic radiolabeled sterols between lipid vesicles Kan, Chu Cheng; Yan, Jiasheng; Bittman, Robert Biochemistry, Vol. 31, Issue 6 https://doi.org/10.1021/bi00121a040	journal	February 1992
Sterol-Modified Phospholipids: Cholesterol and Phospholipid Chimeras with Improved Biomembrane Properties Huang, Zhaohua; Szoka, Francis C. Journal of the American Chemical Society, Vol. 130, Issue 46 https://doi.org/10.1021/ja8065557	journal	October 2008
Structural Studies of the Monolayers and Bilayers Formed by a Novel Cholesterol-Phospholipid Chimera Foglia, F.; Barlow, D. J.; Szoka, F. C. Langmuir, Vol. 27, Issue 13 https://doi.org/10.1021/la200739y	journal	July 2011
Phase I–II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer Harrington, K. J.; Lewanski, C. R.; Northcote, A. D. Annals of Oncology, Vol. 12, Issue 4 https://doi.org/10.1023/A:1011199028318	journal	April 2001
A Phase I Study of SPI-077 (Stealth® Liposomal Cisplatin) Concurrent with Radiation Therapy for Locally Advanced Head and Neck Cancer Rosenthal, David I.; Yom, Sue S.; Liu, Li Investigational New Drugs, Vol. 20, Issue 3, p. 343-349 https://doi.org/10.1023/A:1016201732368	journal	August 2002
Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer White, S. C.; Lorigan, P.; Margison, G. P. British Journal of Cancer, Vol. 95, Issue 7 https://doi.org/10.1038/sj.bjc.6603345	journal	September 2006
The status of platinum anticancer drugs in the clinic and in clinical trials Wheate, Nial J.; Walker, Shonagh; Craig, Gemma E. Dalton Transactions, Vol. 39, Issue 35 https://doi.org/10.1039/c0dt00292e	journal	January 2010
Thermosensitive liposomal cisplatin in combination with local hyperthermia results in tumor growth delay and changes in tumor microenvironment in xenograft models of lung carcinoma Dou, Yannan Nancy; Dunne, Michael; Huang, Huang Journal of Drug Targeting, Vol. 24, Issue 9 https://doi.org/10.1080/1061186X.2016.1191079	journal	June 2016
Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models Bandak, Suzan; Goren, Dorit; Horowitz, Aviva Anti-Cancer Drugs, Vol. 10, Issue 10 https://doi.org/10.1097/00001813-199911000-00007	journal	January 1999
Fast flip-flop of cholesterol and fatty acids in membranes: implications for membrane transport proteins Hamilton, James A. Current Opinion in Lipidology, Vol. 14, Issue 3 https://doi.org/10.1097/00041433-200306000-00006	journal	January 2003
Liposomal cisplatin: a new cisplatin formulation Stathopoulos, George P. Anti-Cancer Drugs, Vol. 21, Issue 8 https://doi.org/10.1097/CAD.0b013e32833d9adf	journal	January 2010
Lipoplatin Treatment in Lung and Breast Cancer Fantini, Manuela; Gianni, Lorenzo; Santelmo, Carlotta Chemotherapy Research and Practice, Vol. 2011 https://doi.org/10.1155/2011/125192	journal	December 2011
Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations Zisman, Natalia; Dos Santos, Nancy; Johnstone, Sharon Chemotherapy Research and Practice, Vol. 2011 https://doi.org/10.1155/2011/213848	journal	January 2011
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects Florea, Ana-Maria; Büsselberg, Dietrich Cancers, Vol. 3, Issue 1 https://doi.org/10.3390/cancers3011351	journal	March 2011

Cited By (5)

Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation No authors listed International Journal of Molecular Sciences, Vol. 21, Issue 2 https://doi.org/10.3390/ijms21020559	journal	January 2020
Liposomal Drug Delivery Systems and Anticancer Drugs Olusanya, Temidayo; Haj Ahmad, Rita; Ibegbu, Daniel Molecules, Vol. 23, Issue 4 https://doi.org/10.3390/molecules23040907	journal	April 2018
Structural Factors Affecting Binding of Platinum Anticancer Agents with Phospholipids: Influence of Charge and Phosphate Clamp Formation Gorle, Anil Kumar; Zhang, Junyong; Liu, Qin Chemistry – A European Journal, Vol. 24, Issue 18 https://doi.org/10.1002/chem.201705822	journal	February 2018
Influence of geometric isomerism on the binding of platinum anticancer agents with phospholipids Gorle, Anil K.; Zhang, Junyong; Berners-Price, Susan J. Dalton Transactions, Vol. 48, Issue 26 https://doi.org/10.1039/c9dt00753a	journal	January 2019
Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview Farooq, Muhammad Asim; Aquib, Md; Farooq, Anum Artificial Cells, Nanomedicine, and Biotechnology, Vol. 47, Issue 1 https://doi.org/10.1080/21691401.2019.1604535	journal	May 2019

Similar Records

Effect of cholesterol on nano-structural alteration of light-activatable liposomes via laser irradiation: Small angle neutron scattering study

Journal Article · Tue Feb 08 23:00:00 EST 2022 · Colloids and Surfaces. A, Physicochemical and Engineering Aspects · OSTI ID:1987802

Glioblastoma Treatment: Bypassing the Toxicity of Platinum Compounds by Using Liposomal Formulation and Increasing Treatment Efficiency With Concomitant Radiotherapy

Journal Article · Sat Sep 01 00:00:00 EDT 2012 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:22149479

Nanosized self-emulsifying lipid vesicles of diacylglycerol-PEG lipid conjugates: Biophysical characterization and inclusion of lipophilic dietary supplements

Journal Article · Mon Apr 12 00:00:00 EDT 2010 · BBA-Biomembranes · OSTI ID:1002321

Related Subjects

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY
59 BASIC BIOLOGICAL SCIENCES
60 APPLIED LIFE SCIENCES
C26 colon carcinoma
Cisplatin
Liposome
X-Ray Fluorescence Microscopy
sterol-modified phospholipid

Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids

Citation Formats

References (39)

Cited By (5)

Similar Records

Related Subjects